Park Avenue Securities LLC Purchases 11,082 Shares of Cardinal Health, Inc. (NYSE:CAH)

Park Avenue Securities LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 168.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,657 shares of the company’s stock after purchasing an additional 11,082 shares during the period. Park Avenue Securities LLC’s holdings in Cardinal Health were worth $1,736,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Clearstead Trust LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth approximately $25,000. Raleigh Capital Management Inc. boosted its holdings in Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after acquiring an additional 268 shares in the last quarter. YHB Investment Advisors Inc. purchased a new position in Cardinal Health during the 1st quarter valued at $32,000. LRI Investments LLC bought a new position in Cardinal Health in the 1st quarter worth $32,000. Finally, Palisade Asset Management LLC purchased a new stake in shares of Cardinal Health in the 1st quarter worth about $34,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 0.2 %

CAH stock traded up $0.19 during midday trading on Wednesday, hitting $99.71. The company’s stock had a trading volume of 1,505,637 shares, compared to its average volume of 2,147,898. Cardinal Health, Inc. has a 12 month low of $85.11 and a 12 month high of $116.04. The firm’s 50-day moving average is $98.57 and its 200-day moving average is $103.32. The company has a market cap of $24.29 billion, a PE ratio of 44.32, a P/E/G ratio of 1.14 and a beta of 0.61.

Analysts Set New Price Targets

CAH has been the subject of a number of research reports. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Argus lowered their target price on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. Robert W. Baird upped their price target on Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 9th. Evercore ISI lowered their price objective on Cardinal Health from $115.00 to $105.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. Finally, Citigroup reduced their target price on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a research report on Friday, July 19th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $109.67.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.